drugset / Trial / NCT05236998
A Pharmacokinetic Study of SID1903 (FDC of Dapagliflozin and Sitagliptin) in Healthy Adult Volunteers
RandomizedCrossoverOpen-labelTreatment
Summary
This study is to compare and evaluate the safety and pharmacokinetic characteristics (PK) after administration of SID1903 and SID1903-R1/SID1903-R2 in healthy adult volunteers.
Timeline
- Start
- 2021-11-03
- Primary completion
- 2021-12-21
- Completion
- 2021-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dapagliflozin | Small molecule | — | Oral |
| Subject | SID1903 | Unknown | — | Oral |
| Subject | Sitagliptin | Small molecule | — | Oral |
Indications
No indication recorded.